Skip to content

Ispire Technology Inc. ISPR Granted (in shares)

Granted (in shares) at other companies

Achieve Life Sciences logo
Achieve Life SciencesACHV
$4.36+32.1%

Other financials

Income statement

See full
Revenue$18.7M-28.7%
Gross profit$2.0M-58.3%
Operating income-$9.5M+10.4%
Net income-$9.5M+12.3%
EPS (diluted)-$0.17+10.5%

Balance sheet

See full
Cash & equivalents$18.0M-23.6%
Total debt$3.8M-40.8%
Total equity-$16.2M-210%
Total assets$75.9M-34.4%

Cash flow

See full
Operating cash flow-$4.0M
CapEx$247.3K
Free cash flow-$4.0M

Valuation

See full
Market cap$64.29M-41.7%
Enterprise value$50.07M-45.1%
P/S0.7×-0.1×

Profitability

See full
Gross margin14.6%-6.6pp
Operating margin-37.7%-871pp
Net margin-38.2%+1,627pp
FCF margin-27.4%-31.5pp

Returns & leverage

See full
Return on equity-223.8%-299pp
Debt / equity9.8×+9.7×
Current ratio0.0×

Where this comes from

Reported directly by Ispire Technology Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.

The official record: Ispire Technology Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Ispire Technology Inc.'s granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ispire Technology Inc.'s granted (in shares)?
Ispire Technology Inc. (ISPR) reported granted (in shares) of $2.70 in Q3 2025.
How has Ispire Technology Inc.'s granted (in shares) changed year-over-year?
Ispire Technology Inc.'s granted (in shares) decreased by 64.7% year-over-year, from $7.65 to $2.70.
What does granted (in shares) mean?
The weighted average exercise price of stock options granted to employees and directors during the reporting period. This metric reflects the company's cost of equity-based incentives and the strike price set for new option awards.